Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction

door Weinstein-Marom, Hadas, Gross, Gideon, Levi, Michal, Brayer, Hadar, Schachter, Jacob, Itzhaki, Orit, Besser, Michal J.
Gepubliceerd in Front Immunol (2021)

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation

door Seliktar-Ofir, Sivan, Merhavi-Shoham, Efrat, Itzhaki, Orit, Yunger, Sharon, Markel, Gal, Schachter, Jacob, Besser, Michal J.
Gepubliceerd in Front Immunol (2017)

Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia

door Rozenbaum, Meir, Meir, Amilia, Aharony, Yarden, Itzhaki, Orit, Schachter, Jacob, Bank, Ilan, Jacoby, Elad, Besser, Michal J.
Gepubliceerd in Front Immunol (2020)

Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex

door Greenberg, Eyal, Hajdu, Steven, Nemlich, Yael, Cohen, Ronit, Itzhaki, Orit, Jacob-Hirsch, Jasmine, Besser, Michal J., Schachter, Jacob, Markel, Gal
Gepubliceerd in 2014

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy

door Yunger, Sharon, Bar El, Assaf, Zeltzer, Li-at, Fridman, Eddie, Raviv, Gil, Laufer, Menachem, Schachter, Jacob, Markel, Gal, Itzhaki, Orit, Besser, Michal J
Gepubliceerd in Oncoimmunology (2019)

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy

door Nissani, Abraham, Lev-Ari, Shaked, Meirson, Tomer, Jacoby, Elad, Asher, Nethanel, Ben-Betzalel, Guy, Itzhaki, Orit, Shapira-Frommer, Ronnie, Schachter, Jacob, Markel, Gal, Besser, Michal J.
Gepubliceerd in J Immunother Cancer (2021)

Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions

door Baruch, Erez Nissim, Ortenberg, Rona, Avivi, Camila, Anafi, Liat, Dick-Necula, Daniela, Stossel, Chani, Moshkovits, Yonatan, Itzhaki, Orit, Besser, Michal Judith, Schachter, Jacob, Barshack, Iris, Markel, Gal
Gepubliceerd in Oncoimmunology (2020)

Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma

door Itzhaki, Orit, Greenberg, Eyal, Shalmon, Bruria, Kubi, Adva, Treves, Avraham J., Shapira-Frommer, Ronnie, Avivi, Camilla, Ortenberg, Rona, Ben-Ami, Eytan, Schachter, Jacob, Besser, Michal J., Markel, Gal
Gepubliceerd in 2013

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs

door Greenberg, Eyal, Hershkovitz, Liat, Itzhaki, Orit, Hajdu, Steven, Nemlich, Yael, Ortenberg, Rona, Gefen, Nir, Edry, Liat, Modai, Shira, Keisari, Yona, Besser, Michal J., Schachter, Jacob, Shomron, Noam, Markel, Gal
Gepubliceerd in 2011

A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme

door Galore-Haskel, Gilli, Nemlich, Yael, Greenberg, Eyal, Ashkenazi, Shira, Hakim, Motti, Itzhaki, Orit, Shoshani, Noa, Shapira-Fromer, Ronnie, Ben-Ami, Eytan, Ofek, Efrat, Anafi, Liat, Besser, Michal J., Schachter, Jacob, Markel, Gal
Gepubliceerd in Oncotarget (2015)

Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients

door Itzhaki, Orit, Jacoby, Elad, Nissani, Abraham, Levi, Michal, Nagler, Arnon, Kubi, Adva, Brezinger, Karin, Brayer, Hadar, Zeltzer, Li-at, Rozenbaum, Meir, Vernitsky, Helly, Markel, Gal, Toren, Amos, Avigdor, Abraham, Schachter, Jacob, Besser, Michal J
Gepubliceerd in J Immunother Cancer (2020)